Sign in to see private stats on your profile page — or add photo, interests, videos, mentoring, etc.

    Jack Resneck Jr., MD

    TitleProfessor
    SchoolUCSF School of Medicine
    DepartmentDermatology
    Address1701 Divisadero
    San Francisco CA 94115
    Phone415-353-9610
    vCardDownload vCard

      Collapse Overview 
      Collapse Overview
      Dr. Resneck is Professor and Vice-Chair of the UCSF Department of Dermatology, and holds a joint appointment as a core faculty member at the Philip R. Lee Institute for Health Policy Studies. He also directs the dermatology faculty practice clinics at UCSF where he previously ran the dermatology residency training program.

      Passionate about advocacy for physicians and patients, Dr. Resneck has held several leadership positions in organized medicine. He is an elected member of the American Medical Association (AMA) Board of Trustees, and previously chaired the AMA’s Council on Legislation. He also chaired the Council on Government Affairs, Health Policy, and Practice of the American Academy of Dermatology (AAD), and is an elected director on the AAD's Board. The AAD has awarded him several presidential citations, as well as its prestigious Clarence S. Livingood Award and Lectureship. He is a past-president of the California Society for Dermatology, and serves on the Editorial Board of the Journal of the American Academy of Dermatology.

      His health policy research examines physician workforce issues, access to outpatient specialty care, the future of academic medicine, the impact of non-physician clinicians, health system reform, the medical liability system, and telehealth. He has authored numerous articles in scientific journals, testified before Congress, been interviewed by major media outlets, and is a sought-after speaker on policy issues. One of his recent studies was instrumental in achieving federal and state policy changes related to ensuring adequacy of insurance provider networks.

      Dr. Resneck is deeply engaged in modernizing medical education and teaching the next generation of physicians, and recently chaired the committee that oversees UCSF’s innovative medical school curriculum. He has a busy clinical practice and cares for patients with a wide range of skin diseases.

      Dr. Resneck's community service endeavors have focused on providing care to patients with HIV-infection and skin disease in East Africa and fundraising for dermatology research. He was also instrumental in passing California’s first-in-the-nation complete ban on indoor tanning by children under the age of 18.

      Dr. Resneck received his B.A. in public policy from Brown University and his M.D. from the University of California, San Francisco. His internship in internal medicine, residency in dermatology, and health policy fellowship were also at UCSF.


      Collapse ORNG Applications 
      Collapse Websites

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Cidre Serrano W, Chren MM, Resneck JS, Aji NN, Pagoto S, Linos E. Online Advertising for Cancer Prevention: Google Ads and Tanning Beds. JAMA Dermatol. 2016 Jan 1; 152(1):101-2. PMID: 26444220.
        View in: PubMed
      2. Linos E, VanBeek M, Resneck JS. Radiation Oncologist Concerns About Increased Electronic Brachytherapy Use for Skin Cancer--Reply. JAMA Dermatol. 2015 Sep; 151(9):1037. PMID: 26177163.
        View in: PubMed
      3. Linos E, VanBeek M, Resneck JS. A Sudden and Concerning Increase in the Use of Electronic Brachytherapy for Skin Cancer. JAMA Dermatol. 2015 Jul; 151(7):699-700. PMID: 25785818.
        View in: PubMed
      4. Resneck JS, VanBeek M. What dermatology still needs to create meaningful patient outcome measurements. JAMA Dermatol. 2015 Apr; 151(4):371-2. PMID: 25549325.
        View in: PubMed
      5. Resneck JS, Quiggle A, Liu M, Brewster DW. The accuracy of dermatology network physician directories posted by Medicare Advantage health plans in an era of narrow networks. JAMA Dermatol. 2014 Dec; 150(12):1290-7. PMID: 25354035.
        View in: PubMed
      6. Wehner MR, Chren MM, Shive ML, Resneck JS, Pagoto S, Seidenberg AB, Linos E. Twitter: an opportunity for public health campaigns. Lancet. 2014 Jul 12; 384(9938):131-2. PMID: 25016994.
        View in: PubMed
      7. Grewal SK, Haas AF, Pletcher MJ, Resneck JS. Compliance by California tanning facilities with the nation's first statewide ban on use before the age of 18 years. J Am Acad Dermatol. 2013 Dec; 69(6):883-889.e4. PMID: 24120564.
        View in: PubMed
      8. Lim HW, Resneck JS, Fischoff R. Research agenda consensus conference. J Am Acad Dermatol. 2013 Aug; 69(2):294. PMID: 23643342.
        View in: PubMed
      9. Resneck JS. Dermatology workforce policy then and now: reflections on Dr Peyton Weary's 1979 manuscript. J Am Acad Dermatol. 2013 Feb; 68(2):338-9. PMID: 23317972.
        View in: PubMed
      10. Resneck JS, Kostecki J. An analysis of dermatologist migration patterns after residency training. Arch Dermatol. 2011 Sep; 147(9):1065-70. PMID: 21931044.
        View in: PubMed
      11. Resneck JS. An analysis of health system reform for dermatologists: elements and implications of the Patient Protection and Affordable Care Act. J Am Acad Dermatol. 2010 Oct; 63(4):706-15. PMID: 20708300.
        View in: PubMed
      12. Resneck JS, VanBeek M. Shared medical appointments: will changes in health care delivery and financing promote increased use of nonphysician clinicians in dermatology patient counseling? Arch Dermatol. 2010 Apr; 146(4):434-6. PMID: 20404236.
        View in: PubMed
      13. Resneck JS, Vanbeek M. Individual drug sampling does not supplant the need for head-to-head trials in dermatology. J Am Acad Dermatol. 2010 Jun; 62(6):1062-3. PMID: 20172624.
        View in: PubMed
      14. Elston DM, Taylor JS, Coldiron B, Hood AF, Read SI, Resneck JS, Kirsner RS, Maize JC, Sullivan S, Laskas J, Hanke CW. Patient safety: Part I. Patient safety and the dermatologist. J Am Acad Dermatol. 2009 Aug; 61(2):179-90; quiz 191. PMID: 19615535.
        View in: PubMed
      15. Feldman SR, Resneck JS. Commentary: The relative ease of obtaining a dermatologic appointment in Boston: how methods drive results. J Am Acad Dermatol. 2009 Jun; 60(6):949-50. PMID: 19467367.
        View in: PubMed
      16. Feramisco JD, Leitenberger JJ, Redfern SI, Bian A, Xie XJ, Resneck JS. A gender gap in the dermatology literature? Cross-sectional analysis of manuscript authorship trends in dermatology journals during 3 decades. J Am Acad Dermatol. 2009 Jan; 60(1):63-9. PMID: 19103359.
        View in: PubMed
      17. Craiglow BG, Resneck JS, Lucky AW, Sidbury R, Yan AC, Resnick SD, Antaya RJ. Pediatric dermatology workforce shortage: perspectives from academia. J Am Acad Dermatol. 2008 Dec; 59(6):986-9. PMID: 18835061.
        View in: PubMed
      18. Kimball AB, Resneck JS. The US dermatology workforce: a specialty remains in shortage. J Am Acad Dermatol. 2008 Nov; 59(5):741-5. PMID: 18723242.
        View in: PubMed
      19. Resneck JS, Kimball AB. Who else is providing care in dermatology practices? Trends in the use of nonphysician clinicians. J Am Acad Dermatol. 2008 Feb; 58(2):211-6. PMID: 18222319.
        View in: PubMed
      20. Resneck JS, Lipton S, Pletcher MJ. Short wait times for patients seeking cosmetic botulinum toxin appointments with dermatologists. J Am Acad Dermatol. 2007 Dec; 57(6):985-9. PMID: 17720277.
        View in: PubMed
      21. Resneck JS, Isenstein A, Kimball AB. Few Medicaid and uninsured patients are accessing dermatologists. J Am Acad Dermatol. 2006 Dec; 55(6):1084-8. PMID: 17097404.
        View in: PubMed
      22. Resneck JS. The influence of controllable lifestyle on medical student specialty choice. Virtual Mentor. 2006; 8(8):529-32. PMID: 23234693.
        View in: PubMed
      23. Tsang MW, Resneck JS. Even patients with changing moles face long dermatology appointment wait-times: a study of simulated patient calls to dermatologists. J Am Acad Dermatol. 2006 Jul; 55(1):54-8. PMID: 16781292.
        View in: PubMed
      24. Resneck JS. Trends in malpractice premiums for dermatologists: results of a national survey. Arch Dermatol. 2006 Mar; 142(3):337-40. PMID: 16549709.
        View in: PubMed
      25. Resneck JS, Kimball AB. Dinners with Irwin: mentorship, the work force, and the future of academic dermatology. J Invest Dermatol. 2006 Mar; 126(3):529-30. PMID: 16482186.
        View in: PubMed
      26. Resneck JS, Tierney EP, Kimball AB. Challenges facing academic dermatology: survey data on the faculty workforce. J Am Acad Dermatol. 2006 Feb; 54(2):211-6. PMID: 16443049.
        View in: PubMed
      27. Jacobson CC, Resneck JS, Kimball AB. Generational differences in practice patterns of dermatologists in the United States: implications for workforce planning. Arch Dermatol. 2004 Dec; 140(12):1477-82. PMID: 15611425.
        View in: PubMed
      28. Resneck JS, Van Beek M, Furmanski L, Oyugi J, LeBoit PE, Katabira E, Kambugu F, Maurer T, Berger T, Pletcher MJ, Machtinger EL. Etiology of pruritic papular eruption with HIV infection in Uganda. JAMA. 2004 Dec 1; 292(21):2614-21. PMID: 15572719.
        View in: PubMed
      29. Resneck J, Luft H. How health policy and health services researchers are compensated: analysis of a nationwide salary survey. Med Care Res Rev. 2004 Sep; 61(3):392-408. PMID: 15358973.
        View in: PubMed
      30. Resneck J, Pletcher MJ, Lozano N. Medicare, Medicaid, and access to dermatologists: the effect of patient insurance on appointment access and wait times. J Am Acad Dermatol. 2004 Jan; 50(1):85-92. PMID: 14699371.
        View in: PubMed
      31. Resneck J, Kimball AB. The dermatology workforce shortage. J Am Acad Dermatol. 2004 Jan; 50(1):50-4. PMID: 14699364.
        View in: PubMed
      32. Maize JC, Resneck JS, Shapiro PE, McCalmont TH, LeBoit PE. Ducking stray "magic bullets": a Melan-A alert. Am J Dermatopathol. 2003 Apr; 25(2):162-5. PMID: 12652201.
        View in: PubMed
      33. Resneck J. Drug samples: friend or foe? J Drugs Dermatol. 2002 Sep; 1(2):124. PMID: 12847734.
        View in: PubMed
      34. Resneck J. Too few or too many dermatologists? Difficulties in assessing optimal workforce size. Arch Dermatol. 2001 Oct; 137(10):1295-301. PMID: 11594852.
        View in: PubMed
      Jack's Networks
      Related Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Related Authors
      People who share related concepts with this person.
      _
      Back to TOP